Publication:
STAT4 RS7574865 GENE POLYMORPHISM IS NOT ASSOCIATED WITH SEVERE DISEASE PHENOTYPE AND RESPONSE TO TUMOR NECROSIS FACTOR-alpha INHIBITOR TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS

dc.contributor.authorsOzen, G.; Saglam, B.; Odabasi, A.; Ozluk, O.; Yentur, S. P.; Saruhan-Direskeneli, G.; Inanc, N.; Direskeneli, H.
dc.date.accessioned2022-03-10T17:53:30Z
dc.date.accessioned2026-01-10T17:24:14Z
dc.date.available2022-03-10T17:53:30Z
dc.date.issued2015
dc.identifier.doi10.1136/annrheumdis-2015-eular.2520
dc.identifier.eissn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttps://hdl.handle.net/11424/221710
dc.identifier.wosWOS:000215799103171
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUP
dc.relation.ispartofANNALS OF THE RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleSTAT4 RS7574865 GENE POLYMORPHISM IS NOT ASSOCIATED WITH SEVERE DISEASE PHENOTYPE AND RESPONSE TO TUMOR NECROSIS FACTOR-alpha INHIBITOR TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPage980
oaire.citation.startPage980
oaire.citation.titleANNALS OF THE RHEUMATIC DISEASES
oaire.citation.volume74

Files